Patents and exclusivity rights currently prevent a company from making a generic Thalomid (thalidomide) product in the United States. However, this may change when the first patent expires in May 2014, unless new patents or lawsuits are filed that would change this date.
Can I Buy Generic Thalomid?Thalomid® (thalidomide) is a prescription medication approved to treat multiple myeloma (cancer that begins in plasma cells) and skin lesions associated with leprosy (known medically as erythema nodosum leprosum). The medication belongs to a group of medicines known as immunomodulators.
Thalomid is made by Celgene Corporation. It is currently under the protection of patents and exclusivity rights that prevent any generic Thalomid from being manufactured in the United States.
When Will Generic Thalomid Be Available?The first patent for Thalomid is set to expire in May 2014. This is the earliest predictable date that a generic version could become available.
However, other circumstances could come up to delay or shorten the exclusivity period. This could include such things as lawsuits or patents for new Thalomid uses. Once Thalomid goes off-patent, there may be several companies that manufacture a generic Thalomid drug.
Is Thalidomide a Generic Thalomid?No -- thalidomide is the active ingredient in Thalomid, but it is not a generic version of it. What can be confusing is that the active ingredient of a drug is often referred to as the "generic name."
The generic name is different from a generic version of a medicine. In order for there to be a generic version, the original medicine must have gone off-patent, and another company besides the original manufacturer must make the product.